Maddaluno, Luigi <br/><br/>
EndMT contributes to the onset and progression of cerebral cavernous malformations.  [electronic resource] 

 -  Nature  Jun 2013 
 - 492-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4687 
<br/><br/><label>Standard No.: </label>10.1038/nature12207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Morphogenetic Protein 6--antagonists & inhibitors<br/>Disease Models, Animal<br/>Disease Progression<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Hemangioma, Cavernous, Central Nervous System--genetics<br/>Humans<br/>KRIT1 Protein<br/>Mice<br/>Microtubule-Associated Proteins--deficiency<br/>Proto-Oncogene Proteins--deficiency<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta--antagonists & inhibitors<br/>Up-Regulation